Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
"Death reported to VAERS" does NOT mean "death caused by a vaccine." VAERS accepts all reports of death occurring after vaccination, regardless of whether the vaccine played any role. Many reported deaths are in elderly individuals who died of pre-existing conditions, coincidental health events, or causes completely unrelated to vaccination. This distinction is essential.
27,732 death reports over 35 years. Context is everything.
When VAERS records a death, it means someone died at some point after receiving a vaccine, and a report was filed. The report does not establish causation. Consider this scenario:
An 85-year-old nursing home resident receives a flu vaccine. Three weeks later, they die of a heart attack related to longstanding coronary artery disease. A death report is filed with VAERS. This death appears in the statistics on this site.
In the United States, approximately 8,000-9,000 people die every day from all causes. When you vaccinate millions of people, some will inevitably die in the days and weeks after vaccination — not because of the vaccine, but because death is a constant occurrence in any large population.
In 2021, VAERS received 11,352 death reports — roughly 59x the pre-COVID average of 192/year. This increase parallels the overall reporting spike and reflects:
The age distribution of death reports closely mirrors the age distribution of natural mortality. Adults 65+ account for 56% of all VAERS death reports. In the general U.S. population, this age group accounts for roughly 75% of all deaths.
This correlation between VAERS death report age distribution and natural mortality age distribution strongly suggests that most reported deaths are coincidental — they would have occurred regardless of vaccination.
VAERS alone cannot determine whether a vaccine caused a death. Causation assessment requires:
When these rigorous methods have been applied, they have confirmed that vaccine-caused deaths are extremely rare. The CDC has stated that after reviewing available clinical data, no causal link has been found between COVID-19 vaccines and most reported deaths.
As VAERS reporting normalizes following the COVID-19 pandemic surge, the data landscape for death report analysis is shifting. Annual VAERS reports in 2025-2026 have returned to the 35,000-45,000 range typical of the pre-pandemic era (2015-2019), making year-over-year comparisons more meaningful again.
The HHS administration has signaled increased focus on vaccine safety data analysis, including the development of AI-powered tools for pattern detection in VAERS reports. While these tools are still under development, they represent a potential evolution in how adverse event data is analyzed and interpreted.
New vaccines entering the market — including RSV vaccines for older adults and pregnant women, updated COVID-19 formulations, and potential H5N1 avian flu vaccines — continue to add new data streams to VAERS. Each new vaccine type provides additional context for understanding death report analysis across the full spectrum of vaccine safety surveillance.
This analysis is based entirely on VAERS passive surveillance data, which carries important limitations that must be understood:
For these reasons, VAERS data is best used for signal detection — identifying potential safety concerns that warrant further investigation — rather than for definitive risk assessment. When VAERS surfaces a potential signal, it is investigated using more rigorous systems like the Vaccine Safety Datalink (VSD) and controlled epidemiological studies.
All data on VaccineWatch comes from the official VAERS public-use datasets published by the CDC and FDA. Our current dataset covers reports from 1990 through early 2026. We process the raw data without filtering or editorializing — every metric is a transparent aggregation of official government data.
As VAERS reporting normalizes following the COVID-19 pandemic surge, the data landscape for death report analysis is shifting. Annual VAERS reports in 2025-2026 have returned to the 35,000-45,000 range typical of the pre-pandemic era (2015-2019), making year-over-year comparisons more meaningful again.
The HHS administration has signaled increased focus on vaccine safety data analysis, including the development of AI-powered tools for pattern detection in VAERS reports. While these tools are still under development, they represent a potential evolution in how adverse event data is analyzed and interpreted.
New vaccines entering the market — including RSV vaccines for older adults and pregnant women, updated COVID-19 formulations, and potential H5N1 avian flu vaccines — continue to add new data streams to VAERS. Each new vaccine type provides additional context for understanding death report analysis across the full spectrum of vaccine safety surveillance.
This analysis is based entirely on VAERS passive surveillance data, which carries important limitations that must be understood:
For these reasons, VAERS data is best used for signal detection — identifying potential safety concerns that warrant further investigation — rather than for definitive risk assessment. When VAERS surfaces a potential signal, it is investigated using more rigorous systems like the Vaccine Safety Datalink (VSD) and controlled epidemiological studies.
All data on VaccineWatch comes from the official VAERS public-use datasets published by the CDC and FDA. Our current dataset covers reports from 1990 through early 2026. We process the raw data without filtering or editorializing — every metric is a transparent aggregation of official government data.